Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-043023
Filing Date
2015-05-14
Accepted
2015-05-14 21:18:41
Documents
1
Period of Report
2015-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4124
  Complete submission text file 0001209191-15-043023.txt   5448
Mailing Address C/O MEDICS 8125 N. HAYDEN RD SCOTTSDALE AZ 85258
Business Address
PRYGOCKI MARK A SR (Reporting) CIK: 0001257544 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 15865113

Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

EIN.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations